GenTrust’s Exelixis EXEL Stock Holding History

GenTrust’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,253	Closed	-$268K	–	237
2026 Q1	$268K	Buy	6,253 +123	+2%	+$5.29K	0.01%	225
2025 Q4	$269K	Buy	+6,130	New	+$254K	0.01%	223

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GenTrust's EXEL Position: Q2 2026 in Review

GenTrust sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 6,253 shares — an estimated $268K sold.

GenTrust first reported a position in EXEL in Q4 2025 and held it in 2 quarters. The position peaked at $269K in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

GenTrust reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
GenTrust sold 6,253 Exelixis shares in Q2 2026, an estimated $268K.
GenTrust first reported a position in Exelixis in Q4 2025 and held it in 2 quarters.
GenTrust's Exelixis position peaked at $269K in Q4 2025.
760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on GenTrust's 13F filing for Q2 2026, filed 6 Aug 2026.